Prevalence of Left Ventricular Diastolic Dysfunction in Patients with Essential Hypertension

Srijana Paudel1, Mani Prasad Gautam1, Yadu Nath Baral1

  • 1National Academy of Medical Sciences, Kathmandu, Nepal.

Insights

Left ventricular diastolic dysfunction (LVDD) affects 33.8% of hypertensive patients. Longer hypertension duration, older age, and higher BMI are linked to LVDD, highlighting the need for early management in essential hypertension.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diastolic Function

Background:

  • Left Ventricular Diastolic Dysfunction (LVDD) is a key factor linking hypertension and heart failure, especially in heart failure with preserved ejection fraction.
  • Understanding LVDD prevalence and associated factors in essential hypertension is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of LVDD in patients with essential hypertension.
  • To identify clinical parameters associated with LVDD in this population.

Main Methods:

  • A hospital-based cross-sectional study was conducted on 68 hypertensive patients.
  • Echocardiography was used to assess LVDD, with results compared to clinical parameters like age, sex, BMI, and dyslipidemia.

Main Results:

  • The prevalence of LVDD was 33.8% among essential hypertensive patients.
  • Hypertension duration over five years (OR 9.14) was significantly associated with LVDD.
  • Age and Body Mass Index (BMI) showed a statistically significant correlation with LVDD (P<0.05).

Conclusions:

  • LVDD is prevalent in patients with essential hypertension.
  • Age, BMI, dyslipidemia, and hypertension duration are significant factors associated with LVDD.
Abstract

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
34
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
23
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K